Chris Storgard insider trades

Open-market stock purchases and sales by Chris Storgard, Chief Medical Officer at Design Therapeutics, Inc, from SEC Form 4 filings since May 16, 2016.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -26%.

Recent trades

DateStockTradeValue
Jan 2, 2026DSGN Design Therapeutics, IncBought (not open market)—

Companies traded

  • DSGN Design Therapeutics, Inc: other filings, last Jan 2, 2026
  • FATE Fate Therapeutics Inc: 1 buy, last Jan 16, 2018

Get free alerts when Chris Storgard files a new trade →